Medicament homogenizing device for pharmacy

Through the crushing and stirring mechanism of the homogenization device of the pharmaceutical agent, the problem of uneven mixing of drugs is solved, efficient mixing and stability of drugs are improved, and waste and cost of raw materials are reduced.

CN223069417UActive Publication Date: 2025-07-08JIANGSU LIANHUAN PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202421992185.4
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2025-07-08
Estimated Expiration
2034-08-16

AI Technical Summary

Technical Problem

When mixing existing pharmaceutical agents, solid medicines and powdered medicines are unevenly mixed, resulting in low working efficiency, inability to refine the medicines, poor stability and uniformity, short shelf life, and waste of raw materials and increased costs.

Method used

A pharmaceutical agent homogenization device is designed, including a crushing mechanism and a stirring mechanism. Solid drugs are crushed through the crushing mechanism, and homogenization of the drugs is achieved by tilting and shaking of the stirring mechanism and the tank body to ensure that the solid particles do not precipitate and mix evenly.

Benefits of technology

It realizes the full mixing of solid drugs and powder drugs, improves work efficiency, enhances the stability and uniformity of drugs, reduces the waste of raw materials, and reduces costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN223069417U_ABST
    Figure CN223069417U_ABST
Patent Text Reader

Abstract

The utility model discloses a medicine homogenizing device for pharmacy, and belongs to the technical field of medicine mechanical equipment. Comprising a tank body, a crushing mechanism and a stirring mechanism, the crushing mechanism and the stirring mechanism are arranged at the upper end of the tank body, the crushing mechanism is communicated with the tank body through a first feeding pipe, and solid medicines enter the crushing mechanism to be crushed, enter the tank body through the first feeding pipe and then are homogenized through the stirring mechanism. According to the utility model, solid medicaments are pretreated through the crushing mechanism and then stirred through the stirring mechanism, so that incomplete homogeneous mixing of the solid medicaments is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model belongs to the technical field of pharmaceutical machinery and equipment, and particularly relates to a pharmaceutical agent homogenizing device for pharmacy. Background Technique

[0002] With the continuous development of the medical cause, the demand for drugs is also increasing year by year, and the forms of drugs are also tending to be diversified. The forms of drugs can usually be divided into solid drugs, liquid drugs and powdered drugs, and each form of drug is very common in medical treatment. When the pharmaceutical agent is formed and produced, it may need to be mixed by a variety of solid drugs, liquid drugs and powdered drugs.

[0003] However, when the solid drugs and powdered drugs in the drug are prepared, when the solid drugs are directly added for homogeneous mixing, it is easy to cause incomplete homogeneous mixing, resulting in low work efficiency, and the drug cannot be refined. The prepared drug has poor stability and uniformity, short shelf life, and in addition, it will cause waste of raw materials, thereby increasing the cost.

[0004] Therefore, it is necessary to provide a pharmaceutical agent homogenizing device for pharmacy. Content of the Utility Model

[0005] Aiming at the deficiencies of the existing technology, the purpose of the utility model is to provide a pharmaceutical agent homogenizing device for pharmacy, which is used to solve the problems of uneven homogeneous mixing of solid drugs and powdered drugs at present, low work efficiency, inability to refine drugs, poor stability and uniformity of the prepared drugs, short shelf life, and waste of raw materials and increased costs.

[0006] To achieve the above purpose, the utility model adopts the following technical solutions:

[0007] A pharmaceutical agent homogenizing device for pharmacy, comprising a tank body, a crushing mechanism and a stirring mechanism arranged at the upper end of the tank body. The crushing mechanism is communicated with the tank body through a first feed pipe. The solid drug enters the crushing mechanism for crushing, enters the interior of the tank body through the first feed pipe, and then is homogenized by the stirring mechanism.

[0008] Further, the crushing mechanism includes a hopper, a discharge pipe and a first chassis. A crushing wheel is arranged in the hopper, and a second driving mechanism, a first driving shaft, a first driving gear, a first driven shaft and a first driven gear are arranged in the first chassis.

[0009] Further, the first driving gear and the first driven gear are meshed and connected.

[0010] Further, the first driving shaft and the first driven shaft are respectively connected to the crushing wheel.

[0011] Further, the stirring mechanism includes a second chassis, a third driving mechanism, a second driving shaft, a second driving gear, a second driven shaft, a second driven gear, and a stirring rod, and the second driven gear is meshed with the second driving gear.

[0012] Further, the second driven shaft penetrates through the second chassis and the tank body and extends into the tank body.

[0013] Further, one side of the tank body is connected to the limiting shaft, and the other side is connected to the output end of the first driving mechanism.

[0014] Further, the limiting shaft is fixedly penetrated on the second support frame, and the first driving mechanism is fixedly penetrated on the first support frame.

[0015] Further, the second support frame and the first support frame are fixed to the upper end of the bearing base, and a fixing frame is also fixed to the upper end of the bearing base.

[0016] Further, a second feed pipe is also provided at the upper end of the tank body.

[0017] Advantages of the present utility model:

[0018] (1) By providing a hopper, when processing pharmaceutical agents, solid drugs are injected into the hopper. When injecting, through the meshing transmission of the first driven gear and the first driving gear, when the second driving mechanism is turned on to drive the first driving shaft to rotate, the first driven shaft is driven to rotate through the meshing transmission of the first driven gear and the first driving gear, so that the two crushing wheels rotate. When the crushing wheels rotate, the injected solid drugs can be crushed, avoiding the influence of over-sized solid drugs on the homogeneous mixing of the agents, and the crushed drugs are discharged through the discharge pipe and received through the first feed pipe, and the agents enter the tank body, thus meeting the pretreatment of solid drugs.

[0019] (2) By providing a tank body, when homogenizing pharmaceutical agents, after the solid agents are injected into the tank body, personnel directly inject powdered drugs and liquid drugs into the tank body through the second feed pipe. After injection, through the meshing transmission of the second driven gear and the second driving gear, when the third driving mechanism is turned on to drive the second driving shaft to rotate, the second driven shaft is driven to rotate through the meshing transmission of the second driven gear and the second driving gear, thereby driving the stirring rod to rotate. When the stirring rod rotates, it homogenizes and mixes the pharmaceutical agents. During mixing, to prevent the solid particles in the agents from precipitating to the bottom, the first driving mechanism is turned on to drive the tank body to tilt back and forth reciprocally to drive the agents to shake, thereby meeting the homogenization of pharmaceutical agents. Description of the drawings

[0020] Figure 1 is a schematic diagram of the overall structure of the present utility model;

[0021] Figure 2 This is a schematic side view structure of the utility model;

[0022] Figure 3 This is a schematic top view structure of the hopper of the utility model;

[0023] Figure 4 This is a schematic cross-sectional view structure of the tank body and the hopper of the utility model;

[0024] Figure 5 This is a schematic rear view structure of the utility model.

[0025] In the figure: 1, support block; 2, bearing base; 3, discharge pipe; 4, first support frame; 5, first driving mechanism; 6, first feed pipe; 7, discharge pipe; 8, first chassis; 9, fixing frame; 10, hopper; 11, second chassis; 12, second feed pipe; 13, limiting shaft; 14, tank body; 15, second support frame; 16, first driving shaft; 17, first driving gear; 18, second driving mechanism; 19, first driven shaft; 20, first driven gear; 21, second driven gear; 22, second driven shaft; 23, third driving mechanism; 24, second driving gear; 25, second driving shaft; 26, stirring rod; 27, crushing wheel. Specific embodiments

[0026] Next, the technical solutions in the present utility model will be clearly and completely described in conjunction with the drawings in the present utility model. In addition, the forms of each structure recorded in the following embodiments are merely examples, and the present utility model is not limited to the structures recorded in the following embodiments. All other embodiments obtained by those of ordinary skill in the art without creative efforts belong to the scope of protection of the present utility model.

[0027] As Figures 1 to 5 shown, the present utility model provides a pharmaceutical agent homogenization device, including a tank body 14 and a crushing mechanism and a stirring mechanism arranged at the upper end of the tank body 14. The crushing mechanism communicates with the tank body 14 through a first feed pipe 6. Solid drugs enter the crushing mechanism for crushing and then enter the interior of the tank body 14 through the first feed pipe 6. Powdered drugs and liquid drugs enter the interior of the tank body 14 through the second feed pipe 12, and then are homogenized through the stirring mechanism. When mixing, to prevent the solid particles in the agent from settling to the bottom, the first driving mechanism 5 is turned on to drive the tank body 14 to tilt back and forth reciprocally to drive the agent to shake, so as to achieve the purpose of complete homogenization. After homogenization is completed, it is discharged through the discharge pipe 3.

[0028] As Figures 1 to 3As shown in the figure, the crushing mechanism includes a hopper 10, a discharge pipe 7, and a first chassis 8. A crushing wheel 27 is provided inside the hopper 10, and a second driving mechanism 18, a first driving shaft 16, a first driving gear 17, a first driven shaft 19, and a first driven gear 20 are provided inside the first chassis 8. The first driving gear 17 and the first driven gear 20 are meshed and connected. The first driving shaft 16 and the first driven shaft 19 are respectively connected to the crushing wheel 27. The first driving shaft 16 is connected to the output end of the second driving mechanism 18. The first driving gear 17 is sleeved on the outer surface of the first driving shaft 16, and the first driven gear 20 is sleeved on the surface of the first driven shaft 19. After the second driving mechanism 18 is connected to the power supply, the output end drives the first driving shaft 16 to rotate, thereby driving the first driving gear 17 to rotate, and then causing the first driven gear 20 meshed with the first driving gear 17 to rotate, driving the first driven shaft 19 to rotate. The rotations of the first driven shaft 19 and the first driving shaft 16 respectively drive the two crushing wheels 27 to rotate relatively. When adding solid drugs into the hopper 10, the solid drugs are crushed to achieve the purpose of pre-treating the solid drugs.

[0029] A discharge pipe 7 is provided at the lower end of the hopper 10. The discharge pipe 7 is internally connected to the inside of the tank body 14 through a first feed pipe 6. The solid drugs crushed in the hopper 10 are sequentially injected into the inside of the tank body 14 through the discharge pipe 7 and the first feed pipe 6 for homogenization. The discharge pipe 7 is a flexible pipe that can be telescoped and can be retracted when the tank body 14 is shaken by the first driving mechanism 5.

[0030] As Figure 1 and 4 As shown in the figure, the stirring mechanism includes a second chassis 11, a third driving mechanism 23, a second driving shaft 25, a second driving gear 24, a second driven shaft 22, a second driven gear 21, and a stirring rod 26. The second driven gear 21 and the second driving gear 24 are meshed and connected. The second chassis 11 is fixed to the upper end of the tank body 14, and the third driving mechanism 23, the second driving shaft 25, the second driving gear 24, the second driven shaft 22, the second driven gear 21, and the stirring rod 26 are all arranged inside the second chassis 11. The third driving mechanism 23 is fixed to the upper end inside the second chassis 11, and the output end is connected to the second driving shaft 25. The upper end of the second driven shaft 22 is fixed to the upper end inside the second chassis 11 and is parallel to the second driving shaft 25. After the third driving mechanism 23 is connected to the power supply, it drives the second driving shaft 25 to rotate, thereby driving the second driving gear 24 sleeved on the outer surface of the second driving shaft 25 to rotate, and then driving the second driven gear 21 to rotate, thereby driving the second driven shaft 22 to rotate.

[0031] The second driven shaft 22 penetrates through the second chassis 11 and the tank body 14 and extends into the interior of the tank body 14. Stirring rods 26 are provided on the surface of the part of the second driven shaft 22 inside the tank body 14. The second driving gear 24 drives the second driven gear 21 to rotate, thereby driving the second driven shaft 22 to rotate. The materials inside the tank body 14 are mixed by the stirring rods 26 provided on the surface of the second driven shaft 22 to achieve the purpose of homogenization.

[0032] The right side of the tank body 14 is connected to the limiting shaft 13, and the left side is connected to the output end of the first driving mechanism 5. After the first driving mechanism 5 is powered on, it drives the tank body 14 to tilt back and forth reciprocally to drive the medicament to shake, so as to achieve the purpose of complete homogenization.

[0033] The limiting shaft 13 penetrates and is fixed on the second support frame 15 to limit one side of the tank body 14, so that the tank body 14 can shake through the first driving mechanism 5, thereby further fully homogenizing the solid drugs, powdered drugs and liquids in the tank body 14, reducing the waste of raw materials, reducing costs, making the drugs refined, and the prepared drugs having excellent stability and uniformity.

[0034] The output end of the first driving mechanism 5 penetrates through the first support frame 4. With the cooperation of the first support frame 4 and the second support frame 15, the tank body 14 is suspended through the first driving mechanism 5 and the limiting shaft 13. After the first driving mechanism 5 is powered on, the drugs in the tank body 14 are shaken for homogenization.

[0035] The second support frame 15 and the first support frame 4 are fixed on the upper end of the bearing base 2. Support blocks 1 are provided at the lower end of the bearing base 2. The support blocks 1 are respectively arranged at the four corners of the lower end of the bearing base 2 to fix the entire device and prevent the tank body 14 from tipping over during the shaking process.

[0036] A second feed pipe 12 is also provided at the upper end of the tank body 14. The powdered drugs and liquid drugs are directly injected into the interior of the tank body 14 from the second feed pipe 12 and mixed with the solid powder crushed by the hopper 10 for homogenization.

[0037] As Figure 1 and 5 shown, a fixing frame 9 is also fixed on the upper end of the bearing base 2. The fixing frame 9 is in an inverted "L" shape. The lower end of the fixing frame 9 is connected to the bearing base 2, and the upper end is connected to the hopper 10 to achieve the purpose of fixing the hopper 10.

[0038] Usage method of the utility model: Solid medicines enter the crushing mechanism for crushing, enter the interior of the tank body 14 through the first feed pipe 6, and powdery medicines and liquid medicines enter the interior of the tank body 14 through the second feed pipe 12, and then are homogenized through the stirring mechanism. When mixing, to prevent the solid particles in the medicine from settling to the bottom, the first driving mechanism 5 is turned on to drive the tank body 14 to tilt back and forth reciprocally to drive the medicine to shake, so as to achieve the purpose of complete homogenization. After the homogenization is completed, it is discharged from the discharge pipe 3.

[0039] The above is only the preferred implementation manner of the utility model. It should be noted that for those of ordinary skill in the art in this technical field, without departing from the principle of the utility model, several improvements and retouches can also be made, and these improvements and retouches should also be regarded as the protection scope of the utility model.

Claims

1. A pharmaceutical agent homogenizing device, characterized in that, It includes a tank body (14), a crushing mechanism and a stirring mechanism arranged at the upper end of the tank body (14). The crushing mechanism communicates with the tank body (14) through a first feed pipe (6). Solid drugs enter the crushing mechanism for crushing, enter the interior of the tank body (14) through the first feed pipe (6), and then are homogenized by the stirring mechanism.

2. The pharmaceutical agent homogenizing device according to claim 1, characterized in that, The crushing mechanism includes a hopper (10), a discharge pipe (7) and a first chassis (8). A crushing wheel (27) is arranged in the hopper (10). A second driving mechanism (18), a first driving shaft (16), a first driving gear (17), a first driven shaft (19) and a first driven gear (20) are arranged in the first chassis (8).

3. The pharmaceutical agent homogenization device according to claim 2, characterized in that, The first driving gear (17) and the first driven gear (20) are meshed and connected.

4. The pharmaceutical agent homogenization device according to claim 2, characterized in that, The first driving shaft (16) and the first driven shaft (19) are respectively connected to the crushing wheel (27).

5. The pharmaceutical agent homogenization device according to claim 1, wherein, The stirring mechanism includes a second chassis (11), a third driving mechanism (23), a second driving shaft (25), a second driving gear (24), a second driven shaft (22), a second driven gear (21) and a stirring rod (26). The second driven gear (21) and the second driving gear (24) are meshed and connected.

6. The pharmaceutical agent homogenizing device according to claim 5, characterized in that, The second driven shaft (22) penetrates through the second chassis (11) and the tank body (14) and extends into the interior of the tank body (14).

7. The pharmaceutical agent homogenizing device according to claim 1, characterized in that, One side of the tank body (14) is connected to a limit shaft (13), and the other side is connected to the output end of a first driving mechanism (5).

8. The pharmaceutical agent homogenization device according to claim 7, characterized in that, The limit shaft (13) penetrates and is fixed on a second support frame (15), and the first driving mechanism (5) penetrates and is fixed on a first support frame (4).

9. The pharmaceutical agent homogenizing device according to claim 8, characterized in that, The second support frame (15) and the first support frame (4) are fixed at the upper end of a bearing base (2). A fixing frame (9) is also fixed at the upper end of the bearing base (2).

10. The pharmaceutical agent homogenizing device according to claim 1, characterized in that, A second feed pipe (12) is also arranged at the upper end of the tank body (14).